Healthcare services PE deal count declined 16% YoY in Q1 2026 from robust Q1 2025 levels, and deal value fell 23.3% despite several megadeals during the quarter. Physician practice management deal count was essentially flat with sluggish Q4 2025 levels and is projected to fall 16.5% YoY; meanwhile, subsegments including dental, dermatology, musculoskeletal, and vision […]
PitchBook Q1 2026 Healthcare Services Report Read More »
You are unauthorized to view this page. Username Password Remember Me Forgot Password
PitchBook Q1 2026 Healthcare Services Report Read More »
After more than a decade of effort, healthcare still struggles with the same consumer pain points: affordability, access, and trust. Despite investments in price transparency, virtual care, and navigation tools, the patient experience remains fragmented, leaving leaders to wonder whether healthcare consumerism ever truly delivered on its promise. In this episode, host Rae Woods invites
Consumerism Still Hasn’t Caught on in Healthcare. Will It Ever? Read More »
You are unauthorized to view this page.
Consumerism Still Hasn’t Caught on in Healthcare. Will It Ever? Read More »
At McDermott’s European Health & Life Sciences Symposium 2026, more than 350 leaders gathered in Paris from across the life sciences and healthcare ecosystem to discuss the trends that are defining the sector’s future. The conversations emphasized how market dynamics, capital allocation, private equity strategies, and the rapid rise of artificial intelligence (AI) are reshaping
European Health & Life Sciences Symposium 2026: Key Takeaways from Paris Read More »
You are unauthorized to view this page.
European Health & Life Sciences Symposium 2026: Key Takeaways from Paris Read More »
On April 13-15, Axinn partners Lisl Dunlop and Leslie Overton and counsel Carol Liu attended the Health Care Transactions Conference hosted by the American Health Law Association (AHLA). In several panels throughout the conference, health care enforcers from the Federal Trade Commission (FTC) and State Attorneys General Offices shared their perspectives on health care antitrust
The traditional approach to negotiating representations and warranties (R&W) and allocating risk in mergers and acquisitions is shifting. As the phased implementation of the “One Big Beautiful Bill Act” (OBBBA) begins and scrutiny of artificial intelligence platforms intensifies at both the state and federal levels, the gap between what a seller is willing to represent
Who Bears the Risk in Healthcare M&A? Impacts of AI and the One Big Beautiful Bill. Read More »
